Bullfrog AI (BFRG) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
5 Oct, 2026Executive summary
Virtual special meeting set for October 15, 2025; August 29 record-date share count was 10,249,805. The Board recommends FOR all four proposals.
Proposals cover up to $10 million in Lincoln Park share sales, a discretionary 1-for-2 to 1-for-15 reverse split, a 750,000-share Plan increase, and possible meeting adjournment.
Voting matters and shareholder proposals
Nasdaq Rule 5635(d) approval would permit issuance above the 2,048,936-share Exchange Cap to Lincoln Park; without approval, below-Minimum-Price sales remain capped.
Approval would allow sales exceeding the Exchange Cap below the $1.4053 Minimum Price, subject to the $10 million agreement limit; greater issuance would dilute voting and economic interests.
Each proposal passes if FOR votes exceed AGAINST votes; abstentions and broker non-votes do not affect proposal outcomes but count toward quorum.
Stockholders may vote online, by phone, mail, or during the virtual meeting; proxies and online or phone votes are due by 11:59 p.m. ET on October 14, 2025.
Board of directors and corporate governance
The Board unanimously approved the reverse-split proposal and may select a ratio from 1-for-2 to 1-for-15, or decline to implement it, based on market, listing and financing factors.
If approved, reverse-split authority expires December 31, 2026; the Board will announce the selected ratio before effectiveness.
Directors and executive officers have interests in proposals only through common-stock ownership and equity awards, including Plan awards.
Latest events from Bullfrog AI
- AI platform targets drug discovery economics, backed by a pharma deal and expanding pipeline.BFRG
LD Micro 20th Annual Main Event Conference - A warrant-resale registration amid early-stage drug development and ongoing funding needs.BFRG
Registration filing - Resale registration could yield up to $3.26M, contingent on cash warrant exercises.BFRG
Registration filing - Four proposals seek a $10M equity facility, reverse-split authority and expanded equity awards.BFRG
Proxy filing - A $100 million shelf backs an early-stage AI drug strategy facing financing and clinical risks.BFRG
Registration filing - Four directors face election as shareholders consider auditor ratification for FY2025.BFRG
Proxy filing - Four director nominees and M & K auditor ratification anchor the 2024 virtual meeting agenda.BFRG
Proxy filing - Amendment updates Item 16 and auditor consent; the continuous-offering framework remains.BFRG
Registration filing - A conditional $10 million equity facility brings potential liquidity and substantial dilution risk.BFRG
Registration filing